Clinical trial

The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis

NCT03331393

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-03-16

PhaseN/A

Study timeline

Study start (actual)2017-03-16Date precision: day

Registry last updated2022-07-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Non-interventionalOTHER

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

GreensboroNorth Carolina, United States1 Beverly HillsCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03331393 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.